Jiudian Pharmaceutical's pain relief plaster shows positive phase 3 trial results

Hunan Jiudian Pharmaceutical Co., Ltd. recently received the Phase 3 clinical trial summary report for its "Jiaoqi Pain Relief Gel Plaster," a traditional Chinese medicine. The trial concluded that the plaster effectively alleviates pain associated with knee osteoarthritis, showing statistically significant improvements in pain scores, pain relief efficacy, WOMAC total scores, and overall efficacy of traditional Chinese medicine syndromes compared to the placebo group. The onset of pain relief was also significantly faster.

The clinical trial also confirmed the good safety profile of the "Jiaoqi Pain Relief Gel Plaster." Minor adverse reactions, such as mild itching and burning sensation at the application site, were occasionally observed but resolved without serious complications, indicating good tolerability among participants. The company aims to apply for registration with the National Medical Products Administration.

Currently, the market for similar pain relief products in traditional Chinese medicine includes various plasters. Hunan Jiudian Pharmaceutical emphasizes the high investment, long development cycles, and inherent risks associated with drug research and development, urging investors to exercise caution.